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Case Study:  Medications and Falls 
Patricia W. Slattum, Pharm.D., Ph.D.  
Research Assistant Professor  
Department of Pharmacy and Pharmaceutics  
Virginia Commonwealth University, Medical College of Virginia Campus  
Clinical Pharmacist  
Heritage Information Systems, Richmond, Virginia 
Dr. Patricia Slattum graduated with a B.S. and Pharm.D. in Pharmacy, a Ph.D. in Pharmaceutics, and a 
Certificate in Aging Studies from MCV/VCU.  She received further training as a geriatric pharmacy fellow 
at McGuire Department of Veterans Affairs Medical Center in Richmond and as an NIH-funded 
postdoctoral fellow in aging and drug disposition at the University of North Carolina at Chapel Hill.  Dr. 
Slattum joined the faculty at MCV/VCU School of Pharmacy in 1996, and serves as principal investigator 
for clinical studies of the effects of age and gender on drug disposition in the body and drug effects on 
the central nervous system.  She also works as a clinical pharmacist with Heritage Information Systems, 
a health care technology company, on initiatives to improve drug therapy outcomes for the elderly. 
Educational Objectives: 
1. To describe potential causes of falls and ways to prevent them.  
2. To illustrate how medications can contribute to an increased risk of falls and recommend strategies 
for reducing this risk. 
Case Study 
Jane Brown is an 83 year old woman who lives with her husband in her own home.  She is active in her 
church and enjoys visiting with her grandchildren and great grandchildren.  She suffers from several 
health problems including heart failure, arthritis, osteoporosis, occasional anxiety, insomnia, and 
cataracts.  More recently she has begun to experience mild confusion, dizziness and depression. Jane 
Brown sees two doctors: a primary care doctor and a cardiologist.  She takes the following medications:  
Digoxin (Lanoxin®) for heart failure  
Furosemide (Lasix®) for heart failure  
Flurazepam (Dalmane®) as needed for insomnia  
Lorazepam (Ativan®) as needed for anxiety  
Amitriptyline (Elavil®) for depression  
Meclizine (Antivert®) for dizziness. 
She also takes acetaminophen or ibuprofen for aches and pains and calcium for her osteoporosis.  She 
obtains her medications from two different pharmacies, depending on which is more convenient.  She is 
enrolled in Medicare and a Medicare Supplemental Insurance program that pays for her prescription 
medications. 
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Last month, she fell against the bathroom sink, bruising her back and chest wall, but she did not feel that 
it was serious enough to consult her doctor.  She has not attended church or been out of the house 
much since the fall. 
Are falls a significant problem? 
Falls in the elderly result in significant medical, social, and financial consequences.  About 30% of people 
age 65 and older living at home will fall each year (Tinetti, 1990).  The number increases to 50% for 
those over age 80.  More than half of ambulatory residents in long term care facilities fall each year.  The 
majority of those who fall experience multiple episodes. Not only does the rate of falls increase with 
age, but the rate of injury from those falls increases as well.  About 5% of people who fall fracture a 
bone, and 1% fracture a hip, resulting in 250,000 hip fractures each year in the U.S.  Accidents, most of 
which are falls, are the sixth leading cause of death in persons over age 65.  It has been estimated that 
the financial cost of caring for those who fall is $12.4 billion per year (Tibbitts, 1996).  Falls are cited as 
the reason for 40% of nursing home admissions.  Falls often result in self-imposed activity restriction 
because of fear of falling, and may lead to withdrawal from normal activities and depression. 
What are the risk factors for falls? 
Falls usually result from a combination of factors related to the individual, the environment, and/or 
medications.  Characteristics of the individual that may contribute to an increased risk of falling include 
disabilities (e.g. muscle weakness or balance impairment), current diseases (e.g. cerebrovascular 
disease, cardiac arrhythmias, dementia, altered mental status, Parkinson's disease, seizure disorders, 
diabetic neuropathy, osteoporosis, cataracts, or a previous fracture), acute illnesses (e.g. infection, 
fever), or age-related changes in vision, hearing or reaction time.  Environmental causes are believed to 
be responsible for about 22% of falls (Tibbitts, 1996).  These factors include poor lighting, obstacles on 
the floor, unstable furniture, low beds or toilets, or inadequate railings on stairs.  Environmental factors 
are particularly significant in unfamiliar surroundings.  Medications are also an important contributor to 
falls.  The total number of medications is a significant factor, with increased risk associated with taking 
four or more drugs (Tibbitts, 1996). Specific drugs or drug classes which can increase risk of falls include 
(Tibbitts, 1996; Kay and Tideiksaar, 1990; Cooper, 1997): 
Drugs which act on the central nervous system:  
* tricyclic antidepressants  
* trazadone  
* monoamine oxidase inhibitor antidepressants  
* antipsychotics  
* barbiturates  
* benzodiazepines  
* drugs which can cause abnormal movements  
* sedating antihistamines. 
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Drugs which act on the cardiovascular system:  
* beta blockers  
* calcium channel blockers  
* reserpine  
* methyldopa  
* vasodilators  
* digoxin. 
Drugs which lower blood sugar:  
* oral hypoglycemics  
* insulin. 
The risk of a fall is increased when medications have been changed within the past two weeks (Tibbits, 
1996).  Adverse drug effects, particularly sedation and dizziness, are usually greater at the initiation of 
treatment before the body begins to become tolerant to the side effects. 
A clinical pharmacist, using a clinical rules system, designed an intervention to reduce the risk of falls in 
the elderly by identifying patients over age 75 who are at higher risk for falls.  Claims data for patients 
enrolled in a Medicare Supplement plan (approximately 70,000 patients) were examined.  Information 
from both insurance and drug claims was used to calculate a risk index.  Each patient's  risk factors were 
evaluated and combined into a risk index: 
Risk index =  
total number of high risk diagnoses +  
total number of high risk medications +  
1 point for taking 4 or more medications +  
1 point for taking 8 or more medications +  
1 point for taking 12 or more medications +  
1 point if being treated by more than one physician. 
Patients with a risk index of 10 or greater were defined as "high risk" for a fall.  Claims for 27,052 
patients over age 75 (average age = 82.3 years) were reviewed.  The average number of drugs per 
patient was 7.3, and the average number of high risk drugs per patient was 2.1.  Patients were seen by 
an average of 2.3 physicians.  A total of  2,211 patients (8%) were determined to be potentially at high 
risk for a fall. 
Jane Brown was one of these patients, with a risk index of 10.  She has osteoporosis (1), cataracts (1) and 
confusion (1); uses 6  prescription medications (1); uses five high risk drugs [digoxin, imipramine, 
lorazepam, flurazepam and meclizine](5); and sees two physicians (1).  The insurance company sent a 
letter to each of Jane Brown's physicians requesting that they review her drug regimen  and consider any 
drug changes that would be appropriate to reduce her fall risk. 
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What can be done to reduce the risk of medication-related falls? 
Prescribers can reduce fall risk due to medications by:  
1. Determining through regular review the indication and ongoing need for each prescribed drug.  
2. Discontinuing drugs of questionable benefit with appropriate clinical follow up.  
3. Substituting a lower risk drug whenever possible.  
4. Identifying patients who are at higher risk for drug adverse events (e.g. advanced age or presumed or 
documented renal impairment) because of an inability to effectively eliminate a drug effectively or 
compensate for the drug's effects, and adjusting dosages as needed.  
5. Advising patients to be careful when ambulating whenever new drugs are begun.  
6. Refraining from using a drug to treat an adverse event of another drug.  
7. Adequately treating conditions such as osteoporosis to reduce the risk of injury after a fall. 
Patients and their families can reduce fall risk due to medications by:  
1. Informing each prescriber and pharmacist of all of the medications being taken, including 
nonprescription products.  
2. Consulting the prescriber whenever an adverse drug reaction may be occurring, especially when 
confusion or loss of balance is noted.  Problems attributed to normal aging may actually be medication 
side effects.  
3. Consulting a doctor or pharmacist when choosing nonprescription products.  
4. Exercising caution in the activities of daily living when starting a new medication, especially those that 
cause sedation, loss of balance, or low blood pressure.  
5. Working with the prescriber to reduce the total number of prescription and nonprescription 
medications. 
Another approach to reducing fall risk is a population-based one as described in this case.  Using 
information technology, medical and pharmacy insurance claims data can be evaluated to identify 
patients at potential risk, and interventions can be designed to reduce that risk. 
Jane Brown visited her primary care doctor to discuss her medications and other health issues.  Over the 
next 6 months, they worked together to reduce her fall risk. 
* The digoxin dose was decreased.  She had been taking digoxin for more than 10 years.  Digoxin is 
eliminated from the body by the kidneys.  Her kidney function had been gradually declining over 
time.  Her dose had become too high, resulting in confusion, dizziness, and drowsiness. 
* The prescription for flurazepam was discontinued.  Flurazepam is a long-acting benzodiazepine that 
can accumulate in the elderly.  Use should be discontinued gradually because dependence develops with 
chronic use.  Flurazepam can also cause dizziness, confusion, and daytime drowsiness and has been 
associated with falls in the elderly.  Non-medication strategies to alleviate insomnia were implemented. 
* Lorazepam was gradually discontinued. Lorazepam is also a benzodiazepine, and the use of two 
benzodiazepines simultaneously can result in additive toxicity.  Lorazepam and flurazepam were 
prescribed by different doctors, who were unaware that Jane Brown was taking two 
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benzodiazepines.  Withdrawal of benzodiazepines can take months and requires a great deal of 
motivation from the patient and the prescriber. 
* Amitriptyline was switched to paroxetine (Paxil®).  Amitriptyline has anticholinergic activity which can 
be associated with sedation, confusion, and impaired cognition in older persons.  It may also lower blood 
pressure.  Paroxetine and other SSRI antidepressants have a more favorable side effect profile in the 
elderly.  An antidepressant may no longer be needed after benzodiazepines and anticholinergic drugs are 
discontinued. 
* Meclizine was discontinued.  Meclizine was prescribed for dizziness that was probably a medication 
side effect.  Meclizine is also an anticholinergic drug and often causes central nervous system side effects 
in the elderly.  
* Jane Brown was referred to a specialist to evaluate her osteoporosis and obtain appropriate treatment, 
including weight bearing exercise and strength training.  
* Strategies to reduce the risk of fall due to the environment were also discussed. 
Summary 
By working together, patients and their health care providers can reduce the risk of falls.  Many factors 
associated with the individual, the environment, and medications contribute to fall risk.  Drug therapy is 
a modifiable risk factor.  A comprehensive review of a patient's drug history often reveals medications 
that were intended to be discontinued earlier, or were continued because of lack of coordination of 
care.  Patients who appear to be "well controlled" on their current medication regimen may actually be 
placed at unnecessarily high risk for adverse drug reactions and falls.  Response to medication can 
change with age-associated changes in physiology.  Ongoing monitoring of drug therapy may minimize 
fall risk. 
Study Questions 
1.  What risk factors contribute to falls?  
2.  What types of medications are particularly problematic when it comes to falls?  
3.  What strategies can be implemented to reduce medication-related fall risk? 
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